Clinical Trial 22713

• Overview

  Study Title:

  A Phase 1a/b Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of GS-9716 as Monotherapy and in Combination with Anticancer Therapies in Patients with Solid Malignancies

• Treatments

  Therapies:

  Antibody-Drug Conjugate; Chemotherapy (NOS); Therapy (NOS)

  Medications:

  GS-9716 (); Sacituzumab Govitecan (); Taxotere (docetaxel); docetaxel ()

If you are interested in learning more about clinical trials, our clinical trial navigators can discuss your options and recommend opportunities that may be suitable for you. Call 813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form.